The deal came as Palo Alto Networks posted higher revenue in its latest quarter and raised its top-line view for the year. ...

Nov 17, 2025 10:05 AM Eastern Standard Time Ardurra Expands California Water Expertise with Acquisition of MKN & Associates Share MIAMI--(BUSINESS WIRE)--Ardurra Group, Inc. (Ardurra), a nationally recognized engineering and consulting firm, is pleased to announce the acquisition of MKN & Associates, Inc. (MKN), a respected California-based firm specializing in water and wastewater engineering services for municipalities and government agencies. Ardurra strengthens its water expertise with the acquisition o ...

Sealed Air has struck a deal to be acquired by private equity firm Clayton Dubilier & Rice in an all-cash transaction with an enterprise value of $10.3 billion. ...

Core Viewpoint - Avadel Pharmaceuticals has received an unsolicited acquisition proposal from H. Lundbeck A/S, valuing Avadel at up to $23.00 per ordinary share, which translates to a total equity value of approximately $2.4 billion, representing a 29% premium over Avadel's closing price prior to the announcement of the Alkermes acquisition [3][4]. Summary by Sections Acquisition Proposal - The Lundbeck Proposal includes $21.00 per ordinary share in cash at closing and a contingent value right (CVR) that could provide additional cash payments of up to $2.00 per share based on sales milestones for LUMRYZ™ and valiloxybate by specified dates [4]. - The proposal is contingent upon various closing conditions, including shareholder approval from Avadel and necessary regulatory approvals [4]. Company Response - Avadel's Board of Directors has determined that the Lundbeck Proposal constitutes a "Company Superior Proposal" under its existing agreement with Alkermes, triggering a five business day negotiation period with Alkermes [5][6]. - During this period, Avadel will discuss any potential amendments to the Alkermes Transaction Agreement that could alter the status of the Lundbeck Proposal [5]. Current Status - The Alkermes Transaction Agreement remains in effect, and Avadel's Board has not changed its recommendation in support of the Alkermes acquisition, indicating no immediate action is required from Avadel shareholders [7]. - Avadel will refrain from further comments on the Lundbeck Proposal until the negotiation period with Alkermes concludes [8]. Financial Advisors - Morgan Stanley and Goldman Sachs are serving as financial advisors to Avadel in relation to the acquisition discussions [10][23].

Core Viewpoint - Alkermes plc acknowledges the announcement by Avadel Pharmaceuticals plc regarding a potential acquisition offer from H. Lundbeck A/S for all issued and to be issued ordinary shares of Avadel [1][2]. Group 1: Transaction Agreement Details - The Transaction Agreement stipulates that Avadel cannot terminate the agreement to pursue a superior proposal unless the board determines that doing so is consistent with its fiduciary duties and that the Lundbeck offer qualifies as a superior proposal [3]. - Avadel must notify Alkermes in writing at least five business days prior to taking any action related to the Lundbeck offer and must engage in good faith discussions with Alkermes regarding any amendments to the Transaction Agreement [3]. Group 2: Future Announcements - Alkermes will make further announcements as appropriate regarding the situation and any developments related to the potential acquisition [4].

Bagsværd, Denmark, 4 November 2025 – On 30 October 2025, Novo Nordisk announced the submission of an unsolicited proposal to acquire Metsera, Inc. (Metsera)1. Today, Novo Nordisk confirms that it has submitted an updated, unsolicited proposal to acquire Metsera. The updated proposal has been declared superior by Metsera’s board of directors. The acquisition of Metsera, including its early and development-stage incretin and non-incretin analogue peptide programmes, would provide Novo Nordisk the opportunity ...

Core Viewpoint - Denny's is being acquired by a group of investors for $620 million, taking the breakfast chain private, with a unanimous board approval [1][2]. Group 1: Acquisition Details - Denny's shareholders will receive $6.25 per share in cash, totaling $322 million, which represents a 52% premium over the closing stock price on the day of the announcement [2]. - The acquisition is led by TriArtisan Capital Advisors, Treville Capital, and Yadav Enterprises, one of Denny's largest franchisees [1][5]. - Denny's shares surged by 47% in after-hours trading following the announcement [2]. Group 2: Company Background - Denny's was founded in 1953 and has undergone several name changes, with its current branding established in 1959 [2]. - The company began trading on the New York Stock Exchange in 1969 [2]. Group 3: Recent Challenges - Denny's experienced a significant decline in sales during the COVID pandemic and has been adapting to changing customer dining preferences, including a shift towards delivery services [3]. - The company has faced competition from newer chains offering healthier breakfast options [3]. - In response to performance issues, Denny's announced plans to close 150 of its lowest-performing locations [4]. Group 4: Future Outlook - Denny's CEO indicated that the board considered multiple offers and believes the acquisition is in the best interest of shareholders [5]. - The deal is expected to close in the first quarter of 2026, pending shareholder approval [6].

Core Viewpoint - The proposed sale of Comerica Incorporated to Fifth Third Bancorp is under investigation to assess whether the transaction adequately values Comerica and the process leading to this valuation is appropriate [1]. Summary by Relevant Sections - **Transaction Details** - Shareholders of Comerica will receive 1.8663 shares of Fifth Third for each share of Comerica they own [1]. - **Legal Investigation** - Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating the proposed sale to determine if the consideration is sufficient or if it undervalues Comerica [1][2].

About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...

Core Viewpoint - Vertiv Holdings announced its acquisition of HVAC services firm PurgeRite Intermediate for approximately $1 billion, aiming to enhance its liquid cooling services portfolio in the data center power equipment sector [1] Group 1: Acquisition Details - The acquisition is valued at around $1 billion, indicating a significant investment by Vertiv Holdings to expand its service offerings [1] - PurgeRite Intermediate specializes in HVAC services, which aligns with Vertiv's strategy to enhance its capabilities in liquid cooling solutions [1] Group 2: Strategic Implications - This move reflects the growing demand for advanced cooling solutions in data centers, highlighting a trend towards more efficient and sustainable technologies in the industry [1] - By integrating PurgeRite's services, Vertiv aims to strengthen its market position and provide comprehensive solutions to its clients [1]